4.0
Jul 31, 2025
Former employee, more than 5 years
Nashville, TN
Recommend
CEO approval
Business Outlook
Pros
Strong exposure to global Phase II–IV trials across various therapeutic areas, including oncology and cardiovascular. Remote flexibility allowed for better work-life balance. Hands-on experience with decentralized trial tools (eConsent, ePRO, telehealth) and clinical systems like CTMS, eTMF, and Medidata Rave. Supportive team culture with cross-functional collaboration. Recognition for high performance through internal awards (e.g., A.C.E. Awards). Opportunities for professional development, including participation in training like Monitoring Excellence Academy.
Cons
Like many CROs, workload can fluctuate depending on study timelines and client demands. Limited upward mobility unless transitioning across departments.